Loading
HKSEConsumer DefensivePackaged Foods
Latest quote
HK$18.40
−HK$0.64 · -3.36%
As an investment holding entity, Health and Happiness (H&H) International Holdings Limited specializes in the global production and distribution of nutritional and care products designed for families and infants. Its offerings are categorized into several key segments. The Infant Formulas division crafts nutritional formulas for children up to age seven, alongside specialized milk products for pregnant and breastfeeding women. The Probiotic Supplements division provides various forms of probiotics, including sachets, capsules, and tablets, catering to the needs of babies, children, and expecting mothers. Within its Adult Nutrition and Care Products segment, H&H develops and markets a range of items such as vitamins, general health supplements, skincare solutions, and sports nutrition for grown-ups. Complementing its infant offerings, the Other Pediatric Products segment focuses on manufacturing dried baby foods, additional nutritional supplements, and general baby care items. Furthermore, its Pet Nutrition and Care segment creates pet food, health-enhancing supplements, and bone broth products for animals. Beyond these core product lines, the company's activities extend to research, development, and processing of diverse ingredients like meat, fruit, and vegetable powders, as well as candies. It actively researches, develops, manufactures, and sells specialized nutritional foods, manages the marketing and distribution of organic baby foods, and handles the wholesale, retail, import, and export of infant nutritional and personal care products. H&H also engages in the trading and sale of adult vitamins, health supplements, probiotic skincare, and sports nutrition items, while offering online sales platforms, software and IT solutions, and packaging services. Its extensive product portfolio is marketed under well-known brands such as Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII. Established in 1999, the company adopted its current name, Health and Happiness (H&H) International Holdings Limited, in June 2017, having previously operated as Biostime International Holdings Limited. Headquartered in Quarry Bay, Hong Kong, H&H functions as a subsidiary of Biostime Pharmaceuticals (China) Limited.
Latest quote
HK$18.40
−HK$0.64 · -3.36%
Regular session · HKT · Market data may be delayed.
As an investment holding entity, Health and Happiness (H&H) International Holdings Limited specializes in the global production and distribution of nutritional and care products designed for families and infants. Its offerings are categorized into several key segments. The Infant Formulas division crafts nutritional formulas for children up to age seven, alongside specialized milk products for pregnant and breastfeeding women. The Probiotic Supplements division provides various forms of probiotics, including sachets, capsules, and tablets, catering to the needs of babies, children, and expecting mothers. Within its Adult Nutrition and Care Products segment, H&H develops and markets a range of items such as vitamins, general health supplements, skincare solutions, and sports nutrition for grown-ups. Complementing its infant offerings, the Other Pediatric Products segment focuses on manufacturing dried baby foods, additional nutritional supplements, and general baby care items. Furthermore, its Pet Nutrition and Care segment creates pet food, health-enhancing supplements, and bone broth products for animals. Beyond these core product lines, the company's activities extend to research, development, and processing of diverse ingredients like meat, fruit, and vegetable powders, as well as candies. It actively researches, develops, manufactures, and sells specialized nutritional foods, manages the marketing and distribution of organic baby foods, and handles the wholesale, retail, import, and export of infant nutritional and personal care products. H&H also engages in the trading and sale of adult vitamins, health supplements, probiotic skincare, and sports nutrition items, while offering online sales platforms, software and IT solutions, and packaging services. Its extensive product portfolio is marketed under well-known brands such as Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII. Established in 1999, the company adopted its current name, Health and Happiness (H&H) International Holdings Limited, in June 2017, having previously operated as Biostime International Holdings Limited. Headquartered in Quarry Bay, Hong Kong, H&H functions as a subsidiary of Biostime Pharmaceuticals (China) Limited.
Day range
Current HK$18.40
52-week range
Current HK$18.40
Regular session · HKT · Market data may be delayed.
As an investment holding entity, Health and Happiness (H&H) International Holdings Limited specializes in the global production and distribution of nutritional and care products designed for families and infants. Its offerings are categorized into several key segments. The Infant Formulas division crafts nutritional formulas for children up to age seven, alongside specialized milk products for pregnant and breastfeeding women. The Probiotic Supplements division provides various forms of probiotics, including sachets, capsules, and tablets, catering to the needs of babies, children, and expecting mothers. Within its Adult Nutrition and Care Products segment, H&H develops and markets a range of items such as vitamins, general health supplements, skincare solutions, and sports nutrition for grown-ups. Complementing its infant offerings, the Other Pediatric Products segment focuses on manufacturing dried baby foods, additional nutritional supplements, and general baby care items. Furthermore, its Pet Nutrition and Care segment creates pet food, health-enhancing supplements, and bone broth products for animals. Beyond these core product lines, the company's activities extend to research, development, and processing of diverse ingredients like meat, fruit, and vegetable powders, as well as candies. It actively researches, develops, manufactures, and sells specialized nutritional foods, manages the marketing and distribution of organic baby foods, and handles the wholesale, retail, import, and export of infant nutritional and personal care products. H&H also engages in the trading and sale of adult vitamins, health supplements, probiotic skincare, and sports nutrition items, while offering online sales platforms, software and IT solutions, and packaging services. Its extensive product portfolio is marketed under well-known brands such as Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII. Established in 1999, the company adopted its current name, Health and Happiness (H&H) International Holdings Limited, in June 2017, having previously operated as Biostime International Holdings Limited. Headquartered in Quarry Bay, Hong Kong, H&H functions as a subsidiary of Biostime Pharmaceuticals (China) Limited.
Day range
Current HK$18.40
52-week range
Current HK$18.40
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14.35B CNY | 13.05B CNY | 13.93B CNY | 12.78B CNY | 11.55B CNY |
| Cost of goods sold | 5.39B CNY | 5.14B CNY | 5.45B CNY | 5.07B CNY | 4.3B CNY |
| Gross profit | 8.96B CNY | 7.92B CNY | 8.47B CNY | 7.7B CNY | 7.25B CNY |
| Research and development | 216.2M CNY | 242.98M CNY | 206.08M CNY | 158.19M CNY | 143.96M CNY |
| Selling, general, and administrative | 7.08B CNY | 6.35B CNY | 6.43B CNY | 5.96B CNY | 5.67B CNY |
| Operating expenses | 7.29B CNY | 6.34B CNY | 6.64B CNY | 5.93B CNY | 5.63B CNY |
| Interest income | 17.22M CNY | 20.57M CNY | 30.23M CNY | 20.02M CNY | 11.88M CNY |
| Interest expense | 685.55M CNY | 869.87M CNY | 807.61M CNY | 530.29M CNY | 263.74M CNY |
| Depreciation and amortization | 216.77M CNY | 300.99M CNY | 302.25M CNY | 311.28M CNY | 305.48M CNY |
| Operating income | 1.67B CNY | 1.57B CNY | 1.83B CNY | 1.61B CNY | 1.51B CNY |
| Net income | 196.14M CNY | −53.72M CNY | 581.85M CNY | 611.78M CNY | 508.48M CNY |
Company facts updated Sep 8, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Total International Stock ETFVXUS5.79M0.00%646.2B USD0.05%$88.41+0.50%
Vanguard FTSE Emerging Markets ETFVWO5.53M0.00%162.3B USD0.06%$61.44+0.74%
iShares Core MSCI EAFE ETFIEFA3.99M0.00%196.63B USD0.07%$101.08+0.13%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS1.84M0.01%13.6B USD0.06%$161.34+0.42%
iShares MSCI EAFE Small-Cap ETFSCZ1.82M0.01%13.23B USD0.40%$87.57+0.10%
iShares Core MSCI Total International Stock ETFIXUS1.13M0.00%61.15B USD0.07%$98.71+0.57%
Dimensional - Emerging Markets Core Equity 2 ETFDFEM945.8K0.01%9.66B USD0.39%$41.00+1.36%
iShares Core MSCI International Developed Markets ETFIDEV777.37K0.00%32.93B USD0.04%$93.41-0.02%Vanguard Total International Stock ETFVXUSVanguard FTSE Emerging Markets ETFVWOiShares Core MSCI EAFE ETFIEFAVanguard FTSE All-World ex-US Small-Cap ETFVSSiShares MSCI EAFE Small-Cap ETFSCZiShares Core MSCI Total International Stock ETFIXUSDimensional - Emerging Markets Core Equity 2 ETFDFEMiShares Core MSCI International Developed Markets ETFIDEVAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
